시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 펩티드 치료제 시장 : 규모, 점유율, 성장 분석, 유형별, 제조업체별, 합성 기술별, 투여 경로별, 용도별, 지역별 업계 예측(2024-2031년)
Peptide Therapeutics Market Size, Share, Growth Analysis, By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Synthesis Technology, By Route of Administration, By Application, By Region - Industry Forecast 2024-2031
상품코드 : 1619081
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 213 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,638,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,936,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,233,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

펩티드 치료제 시장 규모는 2022년에 406억 9,000만 달러로 평가되었고, 예측 기간(2024-2031년)의 CAGR은 5.94%로, 2023년 431억 1,000만 달러에서 2031년에는 684억 달러로 나타날 전망입니다.

펩티드 치료제 수요는 만성 질환의 유병률 증가와 창약에 대한 투자 증가에 의해 크게 성장할 전망입니다. 시장 전망은 더욱 확대될 것으로 보입니다. 위를 밀어 올 것으로 예상됩니다. 암 이환율 증가는 종양학에서 조사 펩티드 치료제의 사용을 촉진하는 반면, 바이오 의약품 연구에 대한 정부의 자금 지원은이 분야의 새로운 기회를 나타냅니다. 그러나 제한된 경구 생체이용률, 높은 제조 비용, 생물학적 제제와의 경쟁과 같은 과제는 장기적인 성장 가능성을 방해할 수 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

펩티드 치료제 시장 규모 : 유형별 및 CAGR(2024-2031년)

펩티드 치료제 시장 규모 : 제조업체별 및 CAGR(2024-2031년)

펩티드 치료제 시장 규모 : 합성 기술 및 CAGR(2024-2031년)

펩티드 치료제 시장 규모 : 투여 경로별 및 CAGR(2024-2031년)

펩티드 치료제 시장 규모 : 용도별 및 CAGR(2024-2031년)

펩티드 치료제 시장 규모 및 CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Peptide Therapeutics Market size was valued at USD 40.69 billion in 2022 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).

The demand for peptide therapeutics is poised for significant growth driven by the escalating prevalence of chronic diseases and increased investment in drug discovery. Awareness of the low toxicity associated with these treatments among patients and healthcare professionals is likely to further enhance market prospects. Innovations in peptide synthesis are anticipated to boost sales, complemented by the rising adoption of targeted therapies known for their precision in addressing various medical conditions. The increasing incidence of cancer will catalyze the use of peptide therapeutics in oncology, while supportive government funding for biopharmaceutical research will unveil new opportunities in the sector. However, challenges such as limited oral bioavailability, high production costs, and competition from biologics may hinder long-term growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peptide Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peptide Therapeutics Market Segmental Analysis

Peptide Therapeutics Market is segmented by Type, Type of Manufacturers, Synthesis Technology, Route of Administration, Application and region. Based on Type, the market is segmented into Generic, Innovative. Based on Type of Manufacturers, the market is segmented into In-house, Outsourced. Based on Synthesis Technology, the market is segmented into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology. Based on Route of Administration, the market is segmented into Parenteral, Oral, Pulmonary, Mucosal, Others. Based on Application, the market is segmented into Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological Disorders, Renal Disorders, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peptide Therapeutics Market

The peptide therapeutics market is significantly driven by the increasing prevalence of chronic diseases, attributed to unhealthy lifestyle choices and habits that have become more common globally. As conditions such as diabetes and cancer continue to rise, there is an escalating demand for more effective and safer treatment options. Peptide therapeutics are particularly favored due to their low toxicity profiles, making them an appealing alternative for patients suffering from various chronic ailments. This growing recognition of peptide treatments as viable solutions underscores their importance in the evolving landscape of medical therapies, further propelling the market forward.

Restraints in the Peptide Therapeutics Market

The Peptide Therapeutics market faces significant restraints, particularly due to the limited oral bioavailability of peptides. When ingested orally, peptides are prone to degradation by digestive enzymes, which significantly restricts their effective administration in this manner. As a result, most peptide therapeutics are delivered through invasive methods like injections. However, many patients are reluctant to choose these invasive options, as they generally favor non-invasive treatment alternatives. This limitation on administration routes poses a challenge for the growth and acceptance of peptide therapeutics in the market, as it reduces patient adherence and overall treatment satisfaction.

Market Trends of the Peptide Therapeutics Market

The peptide therapeutics market is experiencing a significant trend towards the development of oral formulations, a sector currently underexploited compared to injectables. As consumer preference shifts towards non-invasive administration methods, companies that strategically invest in research to create orally bioavailable peptides stand poised to gain a competitive edge. The challenges of oral delivery, such as stability and absorption, are substantial, but the potential rewards are immense, including increased patient compliance and expanded market share. Investments in innovative drug delivery technologies and formulations could yield transformative products, propelling industry growth and establishing new standards in peptide therapeutics by 2025 and beyond.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Peptide Therapeutics Market Size by Type & CAGR (2024-2031)

Global Peptide Therapeutics Market Size by Type of Manufacturers & CAGR (2024-2031)

Global Peptide Therapeutics Market Size by Synthesis Technology & CAGR (2024-2031)

Global Peptide Therapeutics Market Size by Route of Administration & CAGR (2024-2031)

Global Peptide Therapeutics Market Size by Application & CAGR (2024-2031)

Global Peptide Therapeutics Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기